Overview

The Effect of High Dose N-acetylcysteine on Airtrapping and Airway Resistance in Chronic Obstructive Pulmonary Disease (COPD) Patients

Status:
Completed

Trial end date:
2012-02-01

Target enrollment:

Participant gender:

Summary

This study is to investigate the add-on effect of high dose NAC (600mg tablet twice daily) on reduction of airtrapping and airway resistance in stable COPD patients as well as to study it's effect in reducing exacerbation, improving exercise capacity and quality of life in stable COPD patients.

Phase:

Phase 4

Details

Lead Sponsor:

Kwong Wah Hospital

Treatments:

Acetylcysteine
N-monoacetylcystine